{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:28:47Z","timestamp":1760956127754,"version":"3.40.5"},"reference-count":21,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["VHRM"],"DOI":"10.2147\/vhrm.s325217","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T11:40:09Z","timestamp":1631706009000},"page":"571-580","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of Chinese Patients with Hypertriglyceridemia with a Pharmaceutical-Grade Preparation of Highly Purified Omega-3 Polyunsaturated Fatty Acid Ethyl Esters: Main Results of a Randomized, Double-Blind, Controlled Trial"],"prefix":"10.2147","volume":"Volume 17","author":[{"given":"Litong","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingbo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitri","family":"Kazei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Kahler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5407-8773","authenticated-orcid":true,"given":"Yong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12944-016-0286-4","volume":"15","author":"Backes","year":"2016","journal-title":"Lipids Health Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e013543","DOI":"10.1161\/JAHA.119.013543","volume":"8","author":"Hu","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/CIRCULATIONAHA.118.033484","volume":"138","author":"Shen","year":"2018","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.14797\/mdcj-15-3-171","volume":"15","author":"Kris-Etherton","year":"2019","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref5","unstructured":"Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. Zhonghua Xin Xue Guan Bing Za Zhi. 2007;35(4):390\u2013419. Chinese."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.4103\/0366-6999.161361","volume":"128","author":"Zhang","year":"2015","journal-title":"Chin Med J (Engl)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.3748\/wjg.14.4558","volume":"14","author":"Deng","year":"2008","journal-title":"World J Gastroenterol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.jacc.2015.03.544","volume":"65","author":"Schwartz","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"ref9","unstructured":"China Cholesterol Education Program. [Chinese expert consensus on hypertriglyceridemia and hypertriglyceridemia-related cardiovascular risk management]. Zhonghua Xin Xue Guan Bing Za Zhi. 2017;45(2):108\u2013115. Chinese. doi:10.3760\/cma.j.issn.0253-3758.2017.02.008"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Authors\/Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140\u2013205. doi:10.1016\/j.atherosclerosis.2019.08.014","DOI":"10.1016\/j.atherosclerosis.2019.08.014"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e3163","DOI":"10.1002\/dmrr.3163","volume":"35","author":"Wang","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/1753-0407.12887","volume":"11","author":"Li","year":"2019","journal-title":"J Diabetes"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1210\/jc.2016-2477","volume":"102","author":"Lu","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12944-018-0747-z","volume":"17","author":"Jiang","year":"2018","journal-title":"Lipids Health Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.atherosclerosis.2016.02.006","volume":"248","author":"Pan","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/CIRCULATIONAHA.119.043731","volume":"141","author":"Xia","year":"2020","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.clinthera.2017.11.007","volume":"40","author":"Kim","year":"2018","journal-title":"Clin Ther"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4065\/mcp.2009.0397","volume":"85","author":"Bays","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s11883-011-0210-3","volume":"13","author":"Wei","year":"2011","journal-title":"Curr Atheroscler Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.metabol.2016.07.010","volume":"65","author":"Asztalos","year":"2016","journal-title":"Metabolism"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e673","DOI":"10.1161\/CIR.0000000000000709","volume":"140","author":"Skulas-Ray","year":"2019","journal-title":"Circulation"}],"container-title":["Vascular Health and Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=73672","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=73672","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T07:47:02Z","timestamp":1673250422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/treatment-of-chinese-patients-with-hypertriglyceridemia-with-a-pharmac-peer-reviewed-fulltext-article-VHRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":21,"URL":"https:\/\/doi.org\/10.2147\/vhrm.s325217","relation":{},"ISSN":["1178-2048"],"issn-type":[{"type":"electronic","value":"1178-2048"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}